Variations in Guideline‐Concordant Breast Cancer Adjuvant Therapy in Rural Georgia
Authors:
- 10 December 2014
- journal article
- research article
- Published by Wiley in Health Services Research
- Vol. 50 (4) , 1088-1108
Abstract
Objective: To examine factors associated with guideline‐concordant adjuvant therapy among breast cancer patients in a rural region of the United States and to present an advancement in quality‐of‐care assessment in the context of multiple treatments.Data Sources: Chart abstraction on initial therapy received by 868 women diagnosed with primary, invasive, early‐stage breast cancer in a largely rural region of southwest Georgia.Study Design: Using multivariable logistic regression, we examined predictors of adjuvant chemo‐, radiation, and hormonal therapy regimens defined as guideline‐concordant according to the 2000 National Institutes of Health Consensus Development Conference Statement.Principal Findings: Overall, 35.2 percent of women received guideline‐concordant care for all three adjuvant therapies. Higher socioeconomic status was associated with receiving guideline‐concordant care for all three adjuvant therapies jointly, and for chemotherapy. Compared with private insurance, having Medicaid was associated with guideline‐concordant chemotherapy. Unmarried women were more likely to be nonconcordant for chemotherapy and radiation therapy. Increased age predicted nonconcordance for adjuvant therapies jointly, for chemotherapy, and for hormonal therapy.Conclusions: A number of factors were independently associated with receiving guideline‐concordant adjuvant therapy. Identifying and addressing factors that lead to nonconcordance may reduce disparities in treatment and survival.Keywords
This publication has 45 references indexed in Scilit:
- Black–white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the USBreast Cancer Research and Treatment, 2012
- Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivorsCancer, 2010
- Patterns and Correlates of Adjuvant Radiotherapy Receipt After Lumpectomy and After Mastectomy for Breast CancerJournal of Clinical Oncology, 2010
- Underuse of Breast Cancer Adjuvant Treatment: Patient Knowledge, Beliefs, and Medical MistrustJournal of Clinical Oncology, 2009
- Referral, Receipt, and Completion of Chemotherapy in Patients With Early-Stage Breast Cancer Older Than 65 Years and at High Risk of Breast Cancer RecurrenceJournal of Clinical Oncology, 2009
- Parity and disparity in first course treatment of invasive breast cancerBreast Cancer Research and Treatment, 2007
- The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in FloridaBreast Cancer Research and Treatment, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI: Journal of the National Cancer Institute, 2001
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999